Literature DB >> 11997315

Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism.

Marilda Mazzali1, John Kanellis, Lin Han, Lili Feng, Yi-Yang Xia, Qiang Chen, Duk-Hee Kang, Katherine L Gordon, Susumu Watanabe, Takahiko Nakagawa, Hui Y Lan, Richard J Johnson.   

Abstract

Hyperuricemia is associated with hypertension and vascular disease, but whether this represents a causal relationship or an epiphenomenon remains unknown. We recently reported a model of mild hyperuricemia in rats that results in increased blood pressure and mild renal fibrosis. In this study, we examined the effect of hyperuricemia on the renal vasculature. Rats fed 2% oxonic acid and a low-salt diet for 7 wk developed mild hyperuricemia (1.8 vs. 1.4 mg/dl, P < 0.05), hypertension [147 vs. 127 mmHg systolic blood pressure (SBP), P < 0.05], and afferent arteriolar thickening, with a 35% increase in medial area (P < 0.05). Allopurinol or benziodarone prevented the hyperuricemia, hypertension, and arteriolopathy. Hydrochlorothiazide treatment did not prevent the hyperuricemia or arteriolopathy despite controlling blood pressure. In contrast, the arteriolopathy and hypertension were prevented by both enalapril and losartan. Uric acid also directly stimulated vascular smooth muscle cell proliferation in vitro, and this was partially inhibited by losartan. Thus hyperuricemia induces a renal arteriolopathy in rats that is blood pressure independent and involves the renin-angiotensin system.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11997315     DOI: 10.1152/ajprenal.00283.2001

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  229 in total

1.  Fenofibrate and losartan.

Authors:  T Bardin
Journal:  Ann Rheum Dis       Date:  2003-06       Impact factor: 19.103

Review 2.  Are either or both hyperuricemia and xanthine oxidase directly toxic to the vasculature? A critical appraisal.

Authors:  Tuhina Neogi; Jacob George; Sushma Rekhraj; Allan D Struthers; Hyon Choi; Robert A Terkeltaub
Journal:  Arthritis Rheum       Date:  2012-02

3.  Serum uric acid and cardiovascular disease.

Authors:  Adriana Iliesiu; Alexandru Campeanu; Dinu Dusceac
Journal:  Maedica (Buchar)       Date:  2010-07

4.  Effect of uric acid lowering therapy on the prevention of acute kidney injury in cardiovascular surgery.

Authors:  A Ahsan Ejaz; Bhagwan Dass; Vijaykumar Lingegowda; Michiko Shimada; Thomas M Beaver; Noel I Ejaz; Amer S Abouhamze; Richard J Johnson
Journal:  Int Urol Nephrol       Date:  2012-05-31       Impact factor: 2.370

5.  Elevated Serum Uric Acid Is Associated With Greater Risk for Hypertension and Diabetic Kidney Diseases in Obese Adolescents With Type 2 Diabetes: An Observational Analysis From the Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) Study.

Authors:  Petter Bjornstad; Lori Laffel; Jane Lynch; Laure El Ghormli; Ruth S Weinstock; Sherida E Tollefsen; Kristen J Nadeau
Journal:  Diabetes Care       Date:  2019-04-09       Impact factor: 19.112

6.  Xanthine oxidase and uric acid as independent predictors of albuminuria in patients with diabetes mellitus type 2.

Authors:  Aleksandra Klisic; Gordana Kocic; Nebojsa Kavaric; Milovan Jovanovic; Verica Stanisic; Ana Ninic
Journal:  Clin Exp Med       Date:  2017-12-06       Impact factor: 3.984

7.  Uric acid level and erectile dysfunction in patients with coronary artery disease.

Authors:  Yalcin Solak; Hakan Akilli; Mehmet Kayrak; Alpay Aribas; Abduzhappar Gaipov; Suleyman Turk; Santos E Perez-Pozo; Adrian Covic; Kim McFann; Richard J Johnson; Mehmet Kanbay
Journal:  J Sex Med       Date:  2013-09-25       Impact factor: 3.802

8.  Hyperuricemia is associated with progression of IgA nephropathy.

Authors:  Ali Bakan; Alihan Oral; Omer Celal Elcioglu; Mumtaz Takir; Osman Kostek; Abdullah Ozkok; Semih Basci; Abdullah Sumnu; Savas Ozturk; Murat Sipahioglu; Aydın Turkmen; Luminita Voroneanu; Adrian Covic; Mehmet Kanbay
Journal:  Int Urol Nephrol       Date:  2015-03-12       Impact factor: 2.370

9.  Mendelian randomization analysis associates increased serum urate, due to genetic variation in uric acid transporters, with improved renal function.

Authors:  Kim Hughes; Tanya Flynn; Janak de Zoysa; Nicola Dalbeth; Tony R Merriman
Journal:  Kidney Int       Date:  2013-09-18       Impact factor: 10.612

Review 10.  Progressive renal decline as the major feature of diabetic nephropathy in type 1 diabetes.

Authors:  Andrzej S Krolewski; Tomohito Gohda; Monika A Niewczas
Journal:  Clin Exp Nephrol       Date:  2013-11-12       Impact factor: 2.801

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.